A Clinical Trial to Assess the Clinical Benefit of SSR411298 as Adjunctive Treatment for Persistent Cancer Pain

PHASE2TerminatedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

February 29, 2012

Study Completion Date

February 29, 2012

Conditions

PainBreakthrough Cancer Pain

Interventions

DRUG

SSR411298

"Form: tablet~Route: oral administration with food"

DRUG

Placebo (for SSR411298)

"Form: tablet~Route: oral administration with food"

Trial Locations (2)

Investigational Site Number 840006, Flat Rock

Investigational Site Number 840005, Canton